Preferred Label : Maturation;
NCIt synonyms : Development; Developmental;
NCIt definition : The act, or process, of natural progression in physical and psychological maturation
from a previous, lower, or embryonic stage to a later, more complex, or adult stage.;
Origin ID : C17770;
UMLS CUI : C0678723;
Automatic exact mappings (from CISMeF team)
- See also inter- (CISMeF)
- Semantic type(s)
- biological_process_has_initiator_process
- biological_process_involves_gene_product
- biological_process_is_part_of_process
- concept_is_in_subset
- process_includes_biological_process
- process_involves_gene
https://www.has-sante.fr/jcms/p_3488348/fr/developpement-d-un-indicateur-de-resultats-en-obstetrique-mesurant-les-hemorragies-du-post-partum-hpp-a-partir-du-pmsi
2024
France
technical report
resulting in
Maturation
Outcome Assessment, Health Care
SPTA1 wt Allele
weights and measures
obstetrics
paralysis, hyperkalemic periodic
indication of
postpartum hemorrhage, nos
Study Outcome Measure Description
hemorrhage
postpartum hemorrhage
Observational Study Sampling Method
Study Outcome Measurement
Indicator
Development Batch
HPP1 Gene
measures
allopurinol
Development Lot
suggestive of
Hemorrhage
outcome measures
---
https://www.enfant-encyclopedie.com/autisme/selon-experts/autisme-developpement-precoce
2024
Canada
scientific and technical information
autistic disorder
Autism
Development Batch
autistic thinking
Maturation
Development Lot
---
https://www.louvainmedical.be/fr/article/le-developpement-durable-lhopital-aux-sources-de-la-bioethique
2024
Belgium
journal article
Sustainable Development
Development Lot
Development Batch
hospitals
hospital, nos
Subsource
bioethics
Maturation
Biomedical Ethics
---
https://www.louvainmedical.be/fr/article/adapter-la-formation-des-futures-soignantes-pour-les-preparer-aux-enjeux-du-developpement
2024
Belgium
journal article
Preparation
Transition Mutation
future
Sequencing Adapter
Development Batch
habilitation
Sustainable Development
Human Activity Profile
rehabilitation
Adaptation
has provider
Nucleotide Transition Abnormality
Adaptive Study Design Indicator
Adjustment
Development Lot
forecasting
adaptation, nos
Change
caregivers
Transition
Maturation
Training
---
https://cps.ca/fr/documents/position/le-jeu-risque-exterieur
2024
Canada
public health guidelines
injury, nos
risk
child development
Child Individual
Injury
Healthy
Development Batch
injuries
Outdoors
Prevention Study
wounds and injuries
child, nos
Preventive Intervention
Outer
play
Balance
Prevention
Child Relation
Development Lot
Balanced Translocation
play and playthings
Maturation
---
https://www.ineris.fr/sites/ineris.fr/files/contribution/Documents/Charte%20des%20Acteurs_Francopa_VF_novembre%202023_sign%C3%A9%20Ineris.pdf
2024
France
technical report
Vaping
Development Lot
Maturation
Technique
Animal Testing Alternative
animal, nos
Development Batch
panthera uncia
protestantism
animal testing alternatives
---
https://www.enfant-encyclopedie.com/depression-maternelle/selon-experts/incidence-de-la-depression-perinatale-sur-le-developpement-des
2024
Canada
scientific and technical information
depressive disorder
child, nos
Development Batch
depression
perinatal state, nos
incidence
Childhood Depression
Development Lot
Maturation
depression, nos
depression, postpartum
Perinatal Depression
child development
---
https://www.has-sante.fr/jcms/p_3468959/fr/developpement-de-l-indicateur-sur-la-mesure-de-la-recuperation-de-5-complications-post-operatoires
2023
France
technical report
Maturation
postoperative complication, nos
Upset Score 5
Customize
ECOG Performance Status 5
suggestive of
Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery
Operative
Agreement Score 5
Thought Score 5
Recovery
Measurement
Fear Score 5
Development Batch
postoperative complications
Indicator
Gleason Grade Group 5
Measured Tumor Identification
Complication
Intensity and Distress 5
Neck Pain Score 5
Death Related to Adverse Event
Loss of Chromosome 5
Severity of Symptom Score 5
Current Reformed Smoker, Years Unknown
Development Lot
measures
Measurement
Stock Recovery
Alpha-lipoic Acid/Boswellia Serrata Extract/Methylsulfonylmethane/Bromelain Dietary
Supplement
Illness Intrusiveness Rating 5
indication of
Phase V Trial
indicators and reagents
Clinical Status Ordinal Scale Outcome 5
weights and measures
---
https://www.enfant-encyclopedie.com/depression-maternelle/selon-experts/la-depression-de-la-mere-et-sa-relation-avec-le-developpement-et
2023
Canada
scientific and technical information
Maturation
Relative
depression
rehabilitation
child development
mother-child relations
Human Activity Profile
adaptation, nos
depression, nos
Adaptive Study Design Indicator
Relationship
mother, nos
child, nos
CDISC Relationship Class
depressive disorder
Development Batch
habilitation
Relationship
Development Lot
Adaptation
Childhood Depression
Adjustment
---
https://n2t.net/ark:/47881/m600023w
2023
France
dissertations, academic
Family Practice
Cancer Screening
Development Batch
tool, nos
Maturation
patient care management
general practice
Biomedicine
mass screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Substance Screening
Last Screening
Charge
Genetic Screening
screening
Development Lot
Screening Study
Eligibility Determination
teaching
Trial Screening
Tool
Scientific Equipment
Site Screening
Psychological Trauma
pedagogy
---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101200/n/developpement-methode-analytique-composes-organiques-volatils-microbien
2023
France
technical report
Biomarkers
Technique
Exhibition
evaluation studies as topic
Mold
Exposure
volatile organic compounds
Physical Examination
Gigaxonin
CDISC ADAS-Cog - Commands Summary Score
biology
Evaluation
Biomarker
GDC Composition Terminology
mold, nos
Matrix
matrix bands
Analysis
Development Lot
protestantism
Organization Name
Assessment
Other Agency or Organization
Maturation
biology
effects of exposure to external cause, nos
organ component
Assessment
Organism Part
Exposure Domain
Whole Organism
Million Organisms
Organic
Analyte
fungi
Microorganism
Version
Development Batch
GAN Gene
Organic Impurity
Organ
---
https://www.enfant-encyclopedie.com/anxiete-et-depression/selon-experts/la-relation-parent-enfant-pendant-la-petite-enfance-et-le
2023
Switzerland
scientific and technical information
Child Relation
Worry
Anxiety
child development
Early Childhood
Development Lot
Feel Anxious
parent, nos
child, nos
Childhood Depression
depressive disorder
parent-child relations
Anxiety Disorder
depression
Anxiety, CTCAE 3.0
depression, nos
anxiety
anxiety disorder of childhood, nos
Maturation
Development Batch
---
https://www.enfant-encyclopedie.com/tabac-et-grossesse/selon-experts/le-tabagisme-pendant-la-grossesse-et-son-lien-avec-le-developpement
2023
Canada
scientific and technical information
pregnancy
Pregnant
Offspring
Development Lot
Device Smoking
Pregnancy
child, nos
smoking
Child
Development Batch
child development
Maturation
Psychosocial Effect
pregnancy, nos
Tobacco Smoking
---
https://publications.msss.gouv.qc.ca/msss/document-003642/
2023
Canada
journal article
Offspring
Parent
Child
child development
Development Batch
Development Lot
child, nos
Maturation
---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101196/n/developpement-de-strategies-visant-a-controler-le-niveau-de-contamination-des-piscines-par-les-sous-produits-de-desinfection
2023
Canada
technical report
Story
Development Batch
Maturation
Control Group
Scientific Control
Check
pool, nos
Swimming
Supplies
swimming pools
True Control Status
Contamination during Use
Pool
Study Control
Disease Controlled
disinfection
disinfectants
Development Lot
Control
Strategy
disinfectant, nos
---
https://iris.who.int/handle/10665/370812
2023
Switzerland
technical report
NF1 Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
Has No Sibling
Chief Complaint Not Caused by Trauma
Intercurrent Illness is Absent at Onset of Chief Complaint
PDGFRA Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Rheumatic Fever
Preoperative IV Opiates were not Administered
Preoperative IV Sedation was Not Administered
Tumor Progression Absent After Initial Treatment
Nitric Oxide
Chief Complaint was Not Witnessed
Evidence of Disease Absent after Completion of Therapy
Medication Not Taken
No Response to Intervention for Kawasaki Disease
EGFR Gene Amplification Negative
IDH Family Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Unemployed
Regional Anesthesia was not Administered
NON Mouse
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
TP53 Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mentally ill persons
Other Preoperative IV Medications were not Administered
Additional Surgery for New Tumor Event Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Communicable Disorder
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Physician Diagnosed Diabetes Absent
MET Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
EGFR Amplification Analysis Was Not Performed
History of Medical Treatment Absent
BRAF Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
10q23/PTEN Locus Deletion Analysis Was Not Performed
1p/19q Deletion Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Chemical/Occupational Exposure Absent
health status
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
Cancer History Absent
Local Anesthesia Agents were not Administered
No Known History of Alcohol Use
Therapeutic Ionizing Radiation to Head History Absent
Family History of Stomach Cancer Absent
Development Batch
ATRX Gene Mutation Negative
PTEN Gene Mutation Negative
Neither
Norway
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Paraneoplastic Syndrome is Not Present
Another Form of Birth Control was not Used
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Lymph Node Dissection Was Not Performed
No History of Myopathy
SDH Complex Mutation Analysis Was Not Performed
Negation
Routine Cytogenetics Were not Completed
Patient was Not Previously Evaluated for Current Chief Complaint
Hypertension Absent
No History of Gestational Complication
Additional Immunohistochemistry Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Additional Molecular Studies Were Not Performed
Radiation History Negative
NRAS Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
Not Lost to Follow-Up
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use
IV Anesthesia was not Administered
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
RET Rearrangement Analysis Was Not Performed
New Disease is not Multifocal
No History of Non-Cardiac Surgery
First Degree Family History of Primary Brain Tumor Negative
Nitric Oxide Measurement
Any Metastatic Diagnosis Absent
Radiation Therapy Not Received
BRAF Rearrangement Analysis Was Not Performed
Documentation Absent
Preoperative IV Antacids were not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
mental disorders
Minor Criteria for Rheumatic Heart Disease Not Present
Preoperative IV Antiemetics were not Administered
Chemotherapy Not Received
mental health
communicable disease, nos
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
First Degree Family History Cancer Negative
Intervention Not Given for Kawasaki Disease
No History of Neonatal Complication
Noncommunicable Diseases
Patient was not Postmenopausal with no Prior Oophorectomy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
Mental Health
Development Lot
IDH Family Wildtype
Maturation
KIT Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
mental state, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
MGMT Promoter Methylation Testing Was Not Performed
---
https://dumas.ccsd.cnrs.fr/dumas-04131357
2023
France
dissertations, academic
organization
neurology
premature newborn
infant, premature
sleep, nos
organizations
organizers, embryonic
Development Batch
Nervous System
review literature as topic
Optimization
nursing
Daily Living
premature birth of newborn, nos
Sleep
Hour Of Sleep
EPO wt Allele
Preterm Infant
Health Care Organization
Development Lot
infant, newborn
sleep
Nervous System Finding
Reviewing
Maturation
---
https://www.igas.gouv.fr/Evaluation-de-la-situation-economique-et-des-perspectives-de-developpement-des.html
2023
France
technical report
Outlook
central
Proximity
Assessment
Physical Examination
Emergency Room Nursing
nursing service audit
nursing audit
Breast Feeding
economic development
Economics
economics, nursing
OR Nursing
Development Lot
Evaluation
Offer
Outlook Distress
Development Batch
nursing homes
Maturation
delivery of health care
Health Center
costs and cost analysis
Economic Evaluation
Assessment
---
https://dumas.ccsd.cnrs.fr/dumas-04456670
2021
France
dissertations, academic
Development Batch
Development Lot
Medical Examination
play
Gamification
play and playthings
health education, dental
educational measurement
Maturation
tooth, nos
Dental Route of Administration
educational assessment
Health Education
Dental Dosage Form
oral health
---
